乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Oncology/Hematology >

Leukemia

News, opinions and meeting coverage in oncology/hematology.

EHA over a computer rendering of a blood clot

<乌鸦传媒>Combination Ups Survival in Older AML Patients

Frontline venetoclax plus azacitidine adds 5 months to median OS versus azacitidine alone

ASCO over an image of a woman receiving radiotherapy

<乌鸦传媒>Early Palliation: Boon for AML Patients on Intensive Chemo

Intervention led to marked improvements in QoL, mental distress, end-of-life care

AACR over a computer rendering of a tumor

<乌鸦传媒>COVID-19 Mortality Spikes in Patients With Lung, Blood Cancers

Those with metastatic disease also at special risk for poor outcomes

<乌鸦传媒>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds

Apixaban monotherapy matches dalteparin in non-inferiority trial

TRANSPLANTATION & CELLULAR THERAPY over a photo of the Orlando World Center Marriott, Orlando, FL.

<乌鸦传媒>Bringing Transplant to More Patients With AML

Conditioning with radiolabeled antibody leads to successful transplantation in 84% of older patients

TRANSPLANTATION & CELLULAR THERAPY over a photo of the Orlando World Center Marriott, Orlando, FL.

<乌鸦传媒>New CAR-T Makes Case for Aggressive Lymphomas

Largest trial to date shows 73% ORR, 53% CR, potential for outpatient treatment

TRANSPLANTATION & CELLULAR THERAPY over a photo of the Orlando World Center Marriott, Orlando, FL.

<乌鸦传媒>Stem-Cell Transplant Trial Ends in a Draw

Similar PFS with haploidentical bone marrow, double unrelated umbilical cord blood

TRANSPLANTATION & CELLULAR THERAPY over a photo of the Orlando World Center Marriott, Orlando, FL.

<乌鸦传媒>Myeloablative Therapy Prevails in AML Transplant Study

Better survival, fewer relapses compared with reduced-intensity conditioning

TRANSPLANTATION & CELLULAR THERAPY over a photo of the Orlando World Center Marriott, Orlando, FL.

<乌鸦传媒>Better Quality CR With One AML Therapy vs Another?

Longer survival after CR/CRi with CPX-351 than with 7+3 in patients with AML-MRC

A graphic showing the various possibilities of stem cell transplantation

<乌鸦传媒>Gains in Stem Cell Transplant Mortality Over Last 25 Years

But outcomes still "far from perfect"

A medical illustration of shingles

<乌鸦传媒>Higher Risk of Shingles Seen in Patients With Certain Cancers

Vaccine development may help with prevention of herpes zoster in this population

ASH over a photo of Orange County Convention Center, Orlando, FL

<乌鸦传媒>Survival Bump With Oral AML Maintenance

Ten-month OS gain, doubling of RFS with oral azacitidine in transplant-ineligible patients

<乌鸦传媒>IGHV-Unmutated CLL: Gene Signature May Predict Outcomes After First-Line FCR

Prognostic tool may predict who is likely to achieve a relatively long remission

Fludarabine, cyclophosphamide, and rituximab over a chronic lymphocytic leukemia (CLL) blood smear under light microscopy

<乌鸦传媒>FCR Still an Option in IGHV-Unmutated CLL?

Gene signature identifies lower-risk group with greater chemoimmunotherapy benefit

The bottle and packaging of Imbruvica over an electrocardiogram

<乌鸦传媒>Ibrutinib's Cardiotoxicity Comes Into Focus

Study identifies new cardiac events linked to so-called targeted therapy

A photo of the Georgia World Conference Center with the acronym AACR overlaid.

<乌鸦传媒>Overall Survival Data in for Gilteritinib as AML Salvage Tx

FLT3 Inhibitor tops chemotherapy in randomized trial

A young pensive female cancer patient hugging a teddy bear.

<乌鸦传媒>Transplant No Help in Hypodiploid ALL

Similar 5-year outcomes with or without HSCT, regardless of MRD status

2019 SIR Meeting Convention in Austin, Texas

<乌鸦传媒>Are Patients Better Off With Image-Guided Bone Marrow Biopsy?

Prospect of sedation has some going to interventional radiology

<乌鸦传媒>Increased Risk of Chemo-Associated AML for Nearly All Solid Cancers

Extended beyond 5 years for most types with greater risk seen in young patients

<乌鸦传媒>Higher Risk of Shingles Seen in Patients With Certain Cancers

Vaccine development may help with prevention of herpes zoster in this population

<乌鸦传媒>ASH Poster Rounds: Obesity Impacts CLL Survival in Women

Plus: New risk model predicts CLL survival; novel BTK inhibitor works after ibrutinib

<乌鸦传媒>Chemo-Free Tx Tops Best Option in Younger CLL Patients

Improved overall survival and safety with ibrutinib-based therapy

<乌鸦传媒>Add-On Drugs Could Boost Efficacy, Tolerability of CAR T-Cell Therapies

Studies test addition of targeted agents, immunotherapy

<乌鸦传媒>CAR T-Cell Responses Prove Durable in ALL, DLBCL

Two studies demonstrate long-term control in relapsed/refractory disease

<乌鸦传媒>Ibrutinib Alone Wins in Older CLL Patients

Adding rituximab offered no added benefit

<乌鸦传媒>Sneak Peek at Practice-Changing Research From ASH 2018

"Big trials, big results," plus sickle cell disease and CAR T-cell therapies

<乌鸦传媒>Levaquin With Chemo Reduces Bacteremia in Pediatric AML/ALL

But no advantage seen among those undergoing transplant

<乌鸦传媒>FDA Warns Against Long-Term Zmax Use in Certain Cancer Patients

Heightened risk of relapse, death seen in study of stem cell transplant recipients

<乌鸦传媒>Decades Later, Mortality for Childhood Transplant Recipients Remains High

Elevated risk requires closer follow-up care

<乌鸦传媒>Nothing Good for Older Lung Cancer Patients From Add-On Cisplatin

Two trials show no survival benefit and more toxicity

<乌鸦传媒>Second Transplant vs Donor Lymphocyte Infusion in Relapsed AML

Both options viable, benefit more clear in certain groups

<乌鸦传媒>FLT3-ITD Inhibitor Improves Survival in Relapsed AML

More quizartinib-treated patients went on to stem cell transplant

<乌鸦传媒>Lymphoma Risk with JAK Inhibitors for MPNs

Preexisting aberrant B-cell clone implicated

<乌鸦传媒>Ivosidenib Induces Deep Remissions in IDH1-Mutant AML

On strength of phase I data, drug appears headed for FDA approval

<乌鸦传媒>Algorithm Helps Manage Fever

Pediatric cancer patients with non-neutropenic fever could benefit

<乌鸦传媒>Make the Diagnosis: What鈥檚 to Blame for his Rash and Paresthesia?

Case Findings: A 52-year-old man who was undergoing chemotherapy for leukemia went to the ED 5 days after receiving cytarabine. He complained of a rapid onset of erythematous lesions on his palms and soles accompanied by tingling and burning sensations. Can you diagnose the patient?

<乌鸦传媒>New Clues to CAR T-Cell Failure

Chemo effects, T cell energy sources

<乌鸦传媒>Gladiator Blood and Liquid Gold: Good for What Ails You?

A new book by Lydia Kang, MD, reviews the most dubious cures in history

<乌鸦传媒>Mixed Results with Regimens for Older AML Patients

Positive data with venetoclax, liposomal cytarabine-daunorubicin

<乌鸦传媒>Vince DeVita鈥檚 Oncology Opus

Medicine and music share center stage in storied career

5